GPT and metabolic dysfunction-associated steatohepatitis: Although ALT levels and ALT/AST ratio are useful indicators for predicting NAFLD and liver fibrosis, and are often assessed as treatment outcomes, changes in these parameters have a limited ability to reflect NASH resolution or fibrosis regression [38,39].